These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 38689020)
1. Immunopeptidome mining reveals a novel ERS-induced target in T1D. Wang L; Yang S; Zhu G; Li J; Meng G; Chen X; Zhang M; Wang S; Li X; Pan Y; Huang Y; Wang L; Wu Y Cell Mol Immunol; 2024 Jun; 21(6):604-619. PubMed ID: 38689020 [TBL] [Abstract][Full Text] [Related]
2. Proteomic identification of MHC class I-associated peptidome derived from non-obese diabetic mouse thymus and pancreas. Wang L; Li X; Yang S; Chen X; Li J; Wang S; Zhang M; Zheng Z; Zhou J; Wang L; Wu Y J Proteomics; 2023 Jan; 270():104746. PubMed ID: 36210013 [TBL] [Abstract][Full Text] [Related]
3. Selective delivery of beta cell antigen to dendritic cells in vivo leads to deletion and tolerance of autoreactive CD8+ T cells in NOD mice. Mukhopadhaya A; Hanafusa T; Jarchum I; Chen YG; Iwai Y; Serreze DV; Steinman RM; Tarbell KV; DiLorenzo TP Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6374-9. PubMed ID: 18430797 [TBL] [Abstract][Full Text] [Related]
4. Genetic and therapeutic control of diabetogenic CD8+ T cells. Santamaria P Novartis Found Symp; 2008; 292():130-6; discussion 136-45, 202-3. PubMed ID: 19209463 [TBL] [Abstract][Full Text] [Related]
5. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice. Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058 [TBL] [Abstract][Full Text] [Related]
6. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes. Serreze DV; Marron MP; Dilorenzo TP Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821 [TBL] [Abstract][Full Text] [Related]
7. Circulating β cell-specific CD8 Yeo L; Pujol-Autonell I; Baptista R; Eichmann M; Kronenberg-Versteeg D; Heck S; Dolton G; Sewell AK; Härkönen T; Mikk ML; Toppari J; Veijola R; Knip M; Ilonen J; Peakman M Clin Exp Immunol; 2020 Mar; 199(3):263-277. PubMed ID: 31660582 [TBL] [Abstract][Full Text] [Related]
8. HLA-A*0201-restricted T cells from humanized NOD mice recognize autoantigens of potential clinical relevance to type 1 diabetes. Takaki T; Marron MP; Mathews CE; Guttmann ST; Bottino R; Trucco M; DiLorenzo TP; Serreze DV J Immunol; 2006 Mar; 176(5):3257-65. PubMed ID: 16493087 [TBL] [Abstract][Full Text] [Related]
9. The good turned ugly: immunopathogenic basis for diabetogenic CD8+ T cells in NOD mice. DiLorenzo TP; Serreze DV Immunol Rev; 2005 Apr; 204():250-63. PubMed ID: 15790363 [TBL] [Abstract][Full Text] [Related]
10. Inherent ER stress in pancreatic islet β cells causes self-recognition by autoreactive T cells in type 1 diabetes. Marré ML; Profozich JL; Coneybeer JT; Geng X; Bertera S; Ford MJ; Trucco M; Piganelli JD J Autoimmun; 2016 Aug; 72():33-46. PubMed ID: 27173406 [TBL] [Abstract][Full Text] [Related]
11. Identification of autoreactive CD8+ T cell responses targeting chromogranin A in humanized NOD mice and type 1 diabetes patients. Li Y; Zhou L; Li Y; Zhang J; Guo B; Meng G; Chen X; Zheng Q; Zhang L; Zhang M; Wang L Clin Immunol; 2015 Jul; 159(1):63-71. PubMed ID: 25958206 [TBL] [Abstract][Full Text] [Related]
12. Bridging Mice to Men: Using HLA Transgenic Mice to Enhance the Future Prediction and Prevention of Autoimmune Type 1 Diabetes in Humans. Serreze DV; Niens M; Kulik J; DiLorenzo TP Methods Mol Biol; 2016; 1438():137-51. PubMed ID: 27150089 [TBL] [Abstract][Full Text] [Related]
13. CD137 Plays Both Pathogenic and Protective Roles in Type 1 Diabetes Development in NOD Mice. Forsberg MH; Ciecko AE; Bednar KJ; Itoh A; Kachapati K; Ridgway WM; Chen YG J Immunol; 2017 May; 198(10):3857-3868. PubMed ID: 28363905 [TBL] [Abstract][Full Text] [Related]
15. Induction of autoimmune diabetes in non-obese diabetic mice requires interleukin-21-dependent activation of autoreactive CD8⁺ T cells. Chen XL; Bobbala D; Rodriguez GM; Mayhue M; Chen YG; Ilangumaran S; Ramanathan S Clin Exp Immunol; 2013 Aug; 173(2):184-94. PubMed ID: 23607664 [TBL] [Abstract][Full Text] [Related]
16. Generation of β cell-specific human cytotoxic T cells by lentiviral transduction and their survival in immunodeficient human leucocyte antigen-transgenic mice. Babad J; Mukherjee G; Follenzi A; Ali R; Roep BO; Shultz LD; Santamaria P; Yang OO; Goldstein H; Greiner DL; DiLorenzo TP Clin Exp Immunol; 2015 Mar; 179(3):398-413. PubMed ID: 25302633 [TBL] [Abstract][Full Text] [Related]
17. CD8+ T cells in type 1 diabetes. Tsai S; Shameli A; Santamaria P Adv Immunol; 2008; 100():79-124. PubMed ID: 19111164 [TBL] [Abstract][Full Text] [Related]
18. Immunotargeting of insulin reactive CD8 T cells to prevent diabetes. Scott GS; Fishman S; Khai Siew L; Margalit A; Chapman S; Chervonsky AV; Wen L; Gross G; Wong FS J Autoimmun; 2010 Dec; 35(4):390-7. PubMed ID: 20850948 [TBL] [Abstract][Full Text] [Related]
19. Efficient culture of CD8(+) T cells from the islets of NOD mice and their use for the study of autoreactive specificities. Jarchum I; Takaki T; DiLorenzo TP J Immunol Methods; 2008 Nov; 339(1):66-73. PubMed ID: 18782577 [TBL] [Abstract][Full Text] [Related]
20. Level of major histocompatibility complex class I expression on endothelium in non-obese diabetic mice influences CD8 T cell adhesion and migration. Lozanoska-Ochser B; Peakman M Clin Exp Immunol; 2009 Jul; 157(1):119-27. PubMed ID: 19659777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]